$41.62 -0.44 (-1.05%) Mylan N.V. - NASDAQ

Sep. 26, 2016 | 11:20 AM
Last Trade: 41.62
Trade Time: Sep 26 11:20 AM Eastern Daylight Time
Change: -0.44 (-1.05%)
Prev Close: 42.06
Open: 41.79
Bid: 41.61
Ask: 41.62
  1. Time For Congress To Stop Hollering At CEOs And Take Action

    TalkMarkets | Sep. 25, 2016 | 20:12PM EST
  2. Mylan - Should This Stock Be In Your Portfolio?

    TalkMarkets | Sep. 25, 2016 | 04:03AM EST
  3. Wells Fargo And Mylan: Corporate Devils Or Unworthy Scapegoats?

    TalkMarkets | Sep. 23, 2016 | 19:00PM EST
  4. Wells Fargo And Mylan: Corporate Devils Or Scapegoats?

    TalkMarkets | Sep. 23, 2016 | 19:00PM EST
  5. David Einhorn's Top 5 New Q4 Buys

    GuruFocus | Feb. 16, 2016 | 18:51PM EST
  6. Benzinga's M&A Chatter for Wednesday February 10, 2016

    Benzinga | Feb. 10, 2016 | 21:59PM EST
  7. Mylan Will Buy Meda For $9.9 Billion, Q4 Earnings Miss; Stock Dives

    IBD | Feb. 10, 2016 | 17:30PM EST
  8. David Einhorn Rebounds - Somewhat

    GuruFocus | Feb. 9, 2016 | 16:12PM EST
  9. David Einhorn Comments on Mylan

    GuruFocus | Jan. 19, 2016 | 17:32PM EST
  10. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  11. Clinton To Target 'Inversions' With Exit Tax

    FoxBusiness | Dec. 9, 2015 | 14:41PM EST
  12. Pfizer-Allergan Won't Be the Last Inversion

    FoxBusiness | Nov. 23, 2015 | 12:26PM EST
  13. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  14. Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  15. Pfizer-Allergan A Go Despite New Tax Inversion Rules?

    IBD | Nov. 19, 2015 | 19:05PM EST
Trading Center